CX3CL1/Fractalkine Antibody Blocking Peptide, Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition, Each

Details:

A blocking peptide containing 18 amino acids near the amino terminus of human CX3CL1. Source: Synthetic (Accession #: AAB50014) The CX3CL1/Fractalkine Blocking Peptide has been validated for the following applications: Antibody Competition.